Published in Clin Pharmacol Ther on February 03, 2010
Diagnosing the decline in pharmaceutical R&D efficiency. Nat Rev Drug Discov (2012) 5.55
Drug development and clinical trials--the path to an approved cancer drug. Nat Rev Clin Oncol (2012) 4.98
The support of human genetic evidence for approved drug indications. Nat Genet (2015) 3.03
The high cost of cancer drugs and what we can do about it. Mayo Clin Proc (2012) 2.39
Deconstructing the drug development process: the new face of innovation. Clin Pharmacol Ther (2010) 2.38
The impracticality of biomedical rejuvenation therapies: translational and pharmacological barriers. Rejuvenation Res (2014) 2.02
Translating slow-binding inhibition kinetics into cellular and in vivo effects. Nat Chem Biol (2015) 1.83
Envisioning the future of early anticancer drug development. Nat Rev Cancer (2010) 1.67
The therapeutic monoclonal antibody market. MAbs (2015) 1.66
Development of a colon cancer GEMM-derived orthotopic transplant model for drug discovery and validation. Clin Cancer Res (2013) 1.53
A technology platform to assess multiple cancer agents simultaneously within a patient's tumor. Sci Transl Med (2015) 1.43
Predictive Value Tools as an Aid in Chemopreventive Agent Development. J Natl Cancer Inst (2015) 1.40
A celebration of failure. Circulation (2014) 1.38
Pragmatic issues in biomarker evaluation for targeted therapies in cancer. Nat Rev Clin Oncol (2014) 1.28
Unraveling the autoimmune translational research process layer by layer. Nat Med (2012) 1.27
Rational approaches to improving selectivity in drug design. J Med Chem (2012) 1.16
The role of concentration-effect relationships in the assessment of QTc interval prolongation. Br J Clin Pharmacol (2015) 1.09
Drug-drug interaction studies: regulatory guidance and an industry perspective. AAPS J (2013) 1.04
Risk in vaccine research and development quantified. PLoS One (2013) 1.03
Animal models and conserved processes. Theor Biol Med Model (2012) 0.99
Not-in-trial simulation I: Bridging cardiovascular risk from clinical trials to real-life conditions. Br J Clin Pharmacol (2013) 0.99
A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics. J Antibiot (Tokyo) (2015) 0.98
Microfluidic cell culture and its application in high-throughput drug screening: cardiotoxicity assay for hERG channels. J Biomol Screen (2010) 0.96
Developing Exposure/Response Models for Anticancer Drug Treatment: Special Considerations. CPT Pharmacometrics Syst Pharmacol (2015) 0.94
Injury and death in clinical trials and compensation: Rule 122 DAB. Perspect Clin Res (2013) 0.94
Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model. Global Health (2013) 0.93
Translational science by public biotechnology companies in the IPO "class of 2000": the impact of technological maturity. PLoS One (2013) 0.92
Making the biotech IPO work. Nat Biotechnol (2013) 0.90
Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks. Nat Med (2014) 0.90
Peering into the pharmaceutical "pipeline": investigational drugs, clinical trials, and industry priorities. Soc Sci Med (2014) 0.90
Tracking the pharmaceutical pipeline: clinical trials and global disease burden. Clin Transl Sci (2014) 0.89
Neonatal seizures: controversies and challenges in translating new therapies from the lab to the isolette. Eur J Neurosci (2012) 0.89
Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials. ILAR J (2014) 0.88
The scientific quest for lasting youth: prospects for curing aging. Rejuvenation Res (2014) 0.87
Functional magnetic resonance imaging of intrinsic brain networks for translational drug discovery. Trends Pharmacol Sci (2014) 0.87
Replication Validity of Initial Association Studies: A Comparison between Psychiatry, Neurology and Four Somatic Diseases. PLoS One (2016) 0.84
Microfluidic 3D models of cancer. Adv Drug Deliv Rev (2014) 0.84
Microphysiological modeling of the reproductive tract: a fertile endeavor. Exp Biol Med (Maywood) (2014) 0.84
Aurora A kinase regulates non-homologous end-joining and poly(ADP-ribose) polymerase function in ovarian carcinoma cells. Oncotarget (2017) 0.83
Medication Nonadherence, "Professional Subjects," and Apparent Placebo Responders: Overlapping Challenges for Medications Development. J Clin Psychopharmacol (2015) 0.83
Endothelial Cell Vascular Smooth Muscle Cell Co-Culture Assay For High Throughput Screening Assays For Discovery of Anti-Angiogenesis Agents and Other Therapeutic Molecules. Int J High Throughput Screen (2010) 0.83
Characteristics of antimicrobial studies registered in the USA through ClinicalTrials.Gov. Int J Antimicrob Agents (2013) 0.82
ADME of biologics-what have we learned from small molecules? AAPS J (2012) 0.82
Identifying novel interventional strategies for psychiatric disorders: integrating genomics, 'enviromics' and gene-environment interactions in valid preclinical models. Br J Pharmacol (2014) 0.82
Risks of phase I research with healthy participants: A systematic review. Clin Trials (2015) 0.81
Oncology drug development and approval of systemic anticancer therapy by the U.S. Food and Drug Administration. Oncologist (2012) 0.80
Translational research and the evolving landscape for biomedical innovation. J Investig Med (2012) 0.80
Maximizing the value of diagnostics in Alzheimer's disease drug development. Nat Rev Drug Discov (2012) 0.80
The Challenges and Opportunities Associated with Reimbursement for Obesity Pharmacotherapy in the USA. Pharmacoeconomics (2015) 0.79
ChemVassa: A New Method for Identifying Small Molecule Hits in Drug Discovery. Open Med Chem J (2012) 0.79
Deciphering Signaling Pathway Networks to Understand the Molecular Mechanisms of Metformin Action. PLoS Comput Biol (2015) 0.79
More in vivo experimentation is needed in cardiovascular physiology. Am J Physiol Heart Circ Physiol (2014) 0.79
Effect of a pharmacologically induced decrease in core temperature in rats resuscitated from cardiac arrest. Resuscitation (2015) 0.78
Translational utility of rodent hippocampal auditory gating in schizophrenia research: a review and evaluation. Transl Psychiatry (2015) 0.78
A crowdsourcing workflow for extracting chemical-induced disease relations from free text. Database (Oxford) (2016) 0.78
Polypharmacology of small molecules targeting the ubiquitin-proteasome and ubiquitin-like systems. Oncotarget (2015) 0.78
Pharmacodynamic and clinical endpoints for functional colonic disorders: statistical considerations. Dig Dis Sci (2012) 0.78
Improving clinical trial efficiency by biomarker-guided patient selection. Trials (2014) 0.78
Stock market returns and clinical trial results of investigational compounds: an event study analysis of large biopharmaceutical companies. PLoS One (2013) 0.78
Improving anticancer drug development begins with cell culture: misinformation perpetrated by the misuse of cytotoxicity assays. Oncotarget (2016) 0.78
Targeting therapeutic liabilities engendered by PIK3R1 mutations for cancer treatment. Pharmacogenomics (2016) 0.77
Targeting Functional Biomarkers in Schizophrenia with Neuroimaging. Curr Pharm Des (2016) 0.77
Translational medicine: mitigating risks for investigators. Nat Rev Drug Discov (2013) 0.76
A Quantitative Process for Enhancing End of Phase 2 Decisions. Stat Biopharm Res (2014) 0.76
Business models and opportunities for cancer vaccine developers. Hum Vaccin Immunother (2012) 0.76
Emerging proteomic technologies for elucidating context-dependent cellular signaling events: A big challenge of tiny proportions. Proteomics (2015) 0.76
Translating Drugs From Animals to Humans: Do We Need to Prove Efficacy? Transl Vis Sci Technol (2013) 0.76
Variation of Cost among Anti-cancer Drugs Available in Indian Market. J Clin Diagn Res (2016) 0.75
Overview of cancer vaccines: considerations for development. Hum Vaccin Immunother (2012) 0.75
New Zealand's drug development industry. Int J Environ Res Public Health (2013) 0.75
Population Analysis of Adverse Events in Different Age Groups Using Big Clinical Trials Data. JMIR Med Inform (2016) 0.75
A portable and reconfigurable multi-organ platform for drug development with onboard microfluidic flow control. Lab Chip (2016) 0.75
Pharma Success in Product Development—Does Biotechnology Change the Paradigm in Product Development and Attrition. AAPS J (2016) 0.75
Do investors value the FDA orphan drug designation? Orphanet J Rare Dis (2017) 0.75
A critical appraisal of clinical trials conducted and subsequent drug approvals in India and South Africa. BMJ Open (2015) 0.75
Stakeholder views on participant selection for first-in-human trials in cancer nanomedicine. Curr Oncol (2016) 0.75
Reply to Gelman, Gaudart, Pericchi: More reasons to revise standards for statistical evidence. Proc Natl Acad Sci U S A (2014) 0.75
Size of clinical trials and Introductory prices of prophylactic vaccine series. Hum Vaccin Immunother (2012) 0.75
Liquid refreshment. Nat Biotechnol (2013) 0.75
Human genetics as a model for target validation: finding new therapies for diabetes. Diabetologia (2017) 0.75
Use of big data in drug development for precision medicine. Expert Rev Precis Med Drug Dev (2016) 0.75
Expectations for methodology and translation of animal research: a survey of health care workers. BMC Med Ethics (2015) 0.75
Changing R&D models in research-based pharmaceutical companies. J Transl Med (2016) 0.75
Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats. J Nucl Med (2015) 0.75
Active Clinical Trials for Personalized Medicine. J Am Stat Assoc (2016) 0.75
Novel methodology for pharmaceutical expenditure forecast. J Mark Access Health Policy (2014) 0.75
What does the current biotech stock market value? Nat Biotechnol (2015) 0.75
Complementary Approaches to Existing Target Based Drug Discovery for Identifying Novel Drug Targets. Biomedicines (2016) 0.75
Lemons, or Squeezed for Resources? Information Symmetry and Asymmetric Resources in Biotechnology. Front Pharmacol (2017) 0.75
Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity (1999) 8.33
The academic base for general practice: the case for change. BMJ (1993) 5.25
A survey of validity and utility of electronic patient records in a general practice. BMJ (2001) 4.42
Immunologic and psychologic therapy for patients with chronic fatigue syndrome: a double-blind, placebo-controlled trial. Am J Med (1993) 4.41
The VERNALIZATION 2 gene mediates the epigenetic regulation of vernalization in Arabidopsis. Cell (2001) 4.09
Inactivation of Notch 1 in immature thymocytes does not perturb CD4 or CD8T cell development. Nat Immunol (2001) 3.89
An HMG-box-containing T-cell factor required for thymocyte differentiation. Nature (1995) 3.78
Letter: Patient participation in running a primary-care service. Lancet (1975) 3.11
Do single handed practices offer poorer care? Cross sectional survey of processes and outcomes. BMJ (2001) 2.97
Demand incidence and episode rates of ophthalmic disease in a defined urban population. BMJ (1992) 2.96
Study of diagnostic accord between general practitioners and an ophthalmologist. BMJ (1992) 2.96
Helicopters. J R Soc Med (1992) 2.86
Mutations truncating the EP300 acetylase in human cancers. Nat Genet (2000) 2.84
The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol Psychiatry (2006) 2.80
Use of Read codes in development of a standard data set. BMJ (1995) 2.79
The red eye: a general practice survey. J R Coll Gen Pract (1987) 2.47
A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum (2001) 2.37
Estimating an individual's true cholesterol level and response to intervention. JAMA (1991) 2.34
Missed appointments in general practice: retrospective data analysis from four practices. Br J Gen Pract (2001) 2.33
Critical involvement of Tcf-1 in expansion of thymocytes. J Immunol (1998) 2.28
Factors associated with the provision of anti-smoking advice by general practitioners. Br J Gen Pract (1999) 2.19
Survey of practice annual reports. J R Coll Gen Pract (1989) 2.14
Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. Lancet (1996) 2.12
Arabidopsis mutants showing an altered response to vernalization. Plant J (1996) 2.12
Characterization of the immediate-early functions of pseudorabies virus. Virology (1983) 2.12
What's in a name? Public knowledge, attitudes, and experiences with antibiotic use for acute bronchitis. Am J Med (2000) 2.09
Well-established nucleon resonances revisited by double-polarization measurements. Phys Rev Lett (2012) 1.99
Cloning and mapping of a cDNA for methionine synthase reductase, a flavoprotein defective in patients with homocystinuria. Proc Natl Acad Sci U S A (1998) 1.93
Case of Cancer (Epithelioma) of the Tongue in Process of Cure by Shaw-Mackenzie's Method. Proc R Soc Med (1917) 1.92
A murine early thymocyte developmental sequence is marked by transient expression of the interleukin 2 receptor. Proc Natl Acad Sci U S A (1989) 1.92
Anti-smoking advice in general practice consultations: general practitioners' attitudes, reported practice and perceived problems. Br J Gen Pract (1996) 1.91
[Anaphylactoid reactions to colloid plasma substitutes: incidence, risk factors, mechanisms. A French multicenter prospective study]. Ann Fr Anesth Reanim (1994) 1.90
Escherichia coli O157:H7 outbreak associated with an improperly chlorinated swimming pool. Clin Infect Dis (1999) 1.84
Developmental status and reconstitution potential of subpopulations of murine thymocytes. Immunol Rev (1988) 1.82
Transcription of the genome of pseudorabies virus (A herpesvirus) is strictly controlled. Virology (1979) 1.76
High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. Am J Psychiatry (1996) 1.76
Best place of care for older people after acute and during subacute illness: a systematic review. J Health Serv Res Policy (2000) 1.75
N abundance of nodules as an indicator of N metabolism in n(2)-fixing plants. Plant Physiol (1982) 1.75
Pyridostigmine metabolism in man. Clin Pharmacol Ther (1972) 1.74
TRAMP, a novel apoptosis-mediating receptor with sequence homology to tumor necrosis factor receptor 1 and Fas(Apo-1/CD95). Immunity (1997) 1.74
An investigation into the chemical estimation of the oestrogens in urine. Biochem J (1947) 1.71
Characteristics of general practices associated with emergency admission rates to hospital: a cross-sectional study. Emerg Med J (2011) 1.65
Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts. J Exp Med (1993) 1.63
Economic evaluation of hospital at home versus hospital care: cost minimisation analysis of data from randomised controlled trial. BMJ (1999) 1.62
Improved survival among patients treated with adjuvant tamoxifen after mastectomy for early breast cancer. Lancet (1983) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
Prolonged fatigue, anxiety and depression: exploring relationships in a primary care sample. Aust N Z J Psychiatry (1999) 1.58
Maturation of marginal zone and follicular B cells requires B cell activating factor of the tumor necrosis factor family and is independent of B cell maturation antigen. J Exp Med (2001) 1.57
Raising orphans: how clinical development programs of drugs for rare and common diseases are different. Clin Pharmacol Ther (2012) 1.56
Emphysema in young adult survivors of moderate-to-severe bronchopulmonary dysplasia. Eur Respir J (2008) 1.55
Chagas' disease after bone marrow transplantation. Bone Marrow Transplant (1996) 1.51
Limited diversity of T-cell receptor gamma-chain expression of murine Thy-1+ dendritic epidermal cells revealed by V gamma 3-specific monoclonal antibody. Proc Natl Acad Sci U S A (1989) 1.49
Greater sensitivity to subjective effects of nicotine in nonsmokers high in sensation seeking. Exp Clin Psychopharmacol (2000) 1.42
Health promotion in general practice. Room for improvement in data collection. BMJ (1993) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
Repopulation of freeze-dried porcine valves with human fibroblasts and endothelial cells. J Heart Valve Dis (1997) 1.40
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Diffusing capacity limitations of the extent of lung volume reduction surgery in an animal model of emphysema. J Thorac Cardiovasc Surg (1999) 1.39
The reuse of opthalmic Minims: an unacceptable cross-infection risk? Eye (Lond) (2009) 1.39
The Prader-Willi syndrome. Arch Dis Child (1994) 1.39
A group-IV ferromagnetic semiconductor: MnxGe1-x. Science (2002) 1.38
Metabolism of [14C]-neostigmine in the rat. Br J Pharmacol Chemother (1965) 1.38
Disseminated intravascular coagulopathy and thrombocytopenia associated with clozapine-induced neuroleptic malignant syndrome. Aust N Z J Med (1995) 1.38
Extending a pipecuronium neuromuscular block. Increments of atracurium or vecuronium as an alternative to pipecuronium. Anaesthesia (1993) 1.38
Frontal dysfunction in neurologically normal chronic alcoholic subjects: metabolic and neuropsychological findings. Psychol Med (1998) 1.38
Intervention study to evaluate pilot health promotion payment aimed at increasing general practitioners' antismoking advice to smokers. BMJ (2001) 1.37
Toxicity with intravenous injection of crude marijuana extract. Clin Toxicol (1981) 1.36
Disulfiram-ethanol reaction to implanted disulfiram. Can Psychiatr Assoc J (1976) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
A systematic review of discharge arrangements for older people. Health Technol Assess (2002) 1.33
A multi-centre prospective case-control study of campylobacter infection in persons aged 5 years and older in Australia. Epidemiol Infect (2006) 1.33
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
Immature CD4- CD8+ murine thymocytes. Cell Immunol (1988) 1.31
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Social interaction skills and theory of mind in young children. Dev Psychol (1999) 1.27
Notch1 deficiency dissociates the intrathymic development of dendritic cells and T cells. J Exp Med (2000) 1.26
Molecular characterization of T-cell antigen receptor expression by subsets of CD4- CD8- murine thymocytes. Proc Natl Acad Sci U S A (1988) 1.26
Characteristics of general practices associated with emergency-department attendance rates: a cross-sectional study. BMJ Qual Saf (2011) 1.25
Lead arthropathy and systemic lead poisoning from an intraarticular bullet. AJR Am J Roentgenol (2001) 1.24
Segment IV of a Salmonella flagellin gene specifies flagellar antigen epitopes. Mol Microbiol (1991) 1.24
Performance feedback of hand hygiene, using alcohol gel as the skin decontaminant, reduces the number of inpatients newly affected by MRSA and antibiotic costs. J Hosp Infect (2004) 1.24
The effect of adrenalectomy on the blood histamine of rabbits. J Physiol (1941) 1.23
Platelet activating factor and U44069 stimulate a GTPase activity in human platelets which is distinct from the guanine nucleotide regulatory proteins, Ns and Ni. Biochem J (1986) 1.21
LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial. Clin Pharmacol Ther (2012) 1.21
Predicting the outcomes of nursing home patients. Gerontologist (1983) 1.20
Evidence for IL-6 production by and effects on the pancreatic beta-cell. J Immunol (1989) 1.20
Disulfiram implantation in alcoholism treatment. A review. J Stud Alcohol (1975) 1.20
Effect of dietary alpha-linolenic acid on thrombotic risk factors in vegetarian men. Am J Clin Nutr (1999) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
The immunoglobulin mu constant region gene is expressed in mouse thymocytes. Nature (1980) 1.19
The anatomy of category-specific object naming in neurodegenerative diseases. J Cogn Neurosci (2006) 1.19
Extending appointment length--the effect in one practice. J R Coll Gen Pract (1989) 1.19
A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol Psychiatry (2008) 1.18
Clinical approval success rates for investigational cancer drugs. Clin Pharmacol Ther (2013) 1.17
Flanking regulatory sequences of the Tetrahymena R deletion element determine the boundaries of DNA rearrangement. Mol Cell Biol (1999) 1.17
Aneurysms of the pancreaticoduodenal arteries: a change in management. Ann Vasc Surg (1998) 1.16
Helicopter Emergency Medical Services--HEMS One. Ann R Coll Surg Engl (1989) 1.16
Limit-dilution assay and clonal expansion of all T cells capable of proliferation. J Immunol Methods (1982) 1.16